PL3829641T3 - Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji - Google Patents

Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji

Info

Publication number
PL3829641T3
PL3829641T3 PL19748488.4T PL19748488T PL3829641T3 PL 3829641 T3 PL3829641 T3 PL 3829641T3 PL 19748488 T PL19748488 T PL 19748488T PL 3829641 T3 PL3829641 T3 PL 3829641T3
Authority
PL
Poland
Prior art keywords
dry powder
carrier particles
new carrier
powder inhalation
inhalation formulations
Prior art date
Application number
PL19748488.4T
Other languages
English (en)
Inventor
Tomaso GUIDI
Amrit PAUDEL
Sarah Elisabeth ZELLNITZ
Joana Filipa Fernandes TEIXEIRA PINTO
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL3829641T3 publication Critical patent/PL3829641T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
PL19748488.4T 2018-07-27 2019-07-24 Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji PL3829641T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18186078 2018-07-27
PCT/EP2019/069943 WO2020020957A1 (en) 2018-07-27 2019-07-24 Novel carrier particles for dry powder formulations for inhalation

Publications (1)

Publication Number Publication Date
PL3829641T3 true PL3829641T3 (pl) 2024-09-30

Family

ID=63079833

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19748488.4T PL3829641T3 (pl) 2018-07-27 2019-07-24 Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji

Country Status (12)

Country Link
US (1) US11813360B2 (pl)
EP (1) EP3829641B1 (pl)
JP (1) JP7439084B2 (pl)
KR (1) KR102784384B1 (pl)
CN (1) CN112469443B (pl)
AU (1) AU2019311268B2 (pl)
BR (1) BR112021001402A2 (pl)
ES (1) ES2981460T3 (pl)
MA (1) MA53324A (pl)
MX (1) MX2021000779A (pl)
PL (1) PL3829641T3 (pl)
WO (1) WO2020020957A1 (pl)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2601973Y2 (ja) 1993-06-17 1999-12-13 積水ハウス株式会社 旗取付具
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
CA2427991C (en) * 2000-11-06 2008-01-22 Asahi Kasei Kabushiki Kaisha Cellulose particles for pharmaceuticals
JP2005506956A (ja) * 2001-06-01 2005-03-10 イーライ・リリー・アンド・カンパニー 長時間作用性ｇｌｐ−１製剤
DE60239639D1 (de) 2002-07-31 2011-05-12 Chiesi Farma Spa Pulverinhalator
WO2004073827A1 (en) 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
JP2008524317A (ja) * 2004-12-21 2008-07-10 ファイザー・プロダクツ・インク 腸溶コーティングされたアジスロマイシン多粒子
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
BRPI0912014A2 (pt) * 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
CN102149437B (zh) 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
EP2216327A1 (en) 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
CN102811715A (zh) * 2009-12-08 2012-12-05 悉尼大学 可吸入制剂
EP2601973A1 (en) * 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
US9554992B2 (en) * 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic

Also Published As

Publication number Publication date
JP2021531948A (ja) 2021-11-25
AU2019311268A1 (en) 2021-02-11
AU2019311268B2 (en) 2025-01-16
US11813360B2 (en) 2023-11-14
CA3105265A1 (en) 2020-01-30
MX2021000779A (es) 2021-03-31
US20210290540A1 (en) 2021-09-23
MA53324A (fr) 2021-06-09
KR102784384B1 (ko) 2025-03-21
CN112469443B (zh) 2024-04-16
KR20210040102A (ko) 2021-04-12
EP3829641A1 (en) 2021-06-09
BR112021001402A2 (pt) 2021-04-27
EP3829641B1 (en) 2024-05-22
CN112469443A (zh) 2021-03-09
JP7439084B2 (ja) 2024-02-27
WO2020020957A1 (en) 2020-01-30
ES2981460T3 (es) 2024-10-09

Similar Documents

Publication Publication Date Title
EP3668490A4 (en) Dry powder compositions for intranasal delivery
EP3407870A4 (en) dry powder inhaler
DK3612259T3 (da) Enhedsdosistørpulverinhalator
EP3107548B8 (en) Dry powder formulations for inhalation
DK3325059T3 (da) Tørpulverinhalator
HUE072078T2 (hu) Szilárd részecskéket magába záró hidrogél készítmények
IL269448A (en) Optical dry powder inhaler dose sensor
ZA201703077B (en) Dry powder inhaler
EP3858802A4 (en) COATED SILICON CARBIDE PARTICLE POWDER
EP3714928A4 (en) NEW DRY POWDER INHALER
IL263365A (en) Dry powder inhaler
DK3138600T3 (da) Tørpulverinhalator
PL3541200T3 (pl) Formulacje proszkowe
DK3621682T3 (da) Tørpulverinhalator
DK3179986T3 (da) Tørpulverformuleringer til inhalation
EP3463378A4 (en) DRY POWDER FORMULAS FOR INHALATION
IL261459A (en) Stable formulations for lyophilizing therapeutic particles
EP3941438A4 (en) INHALABLE DRY POWDER
DK3413864T3 (da) Pulversammensætning til luftpolering
HUE040504T2 (hu) Lélegzõvel mûködtetett száraz por inhalátor
GB201511942D0 (en) Dry powder inhaler apparatus
EP3400214C0 (en) COMPOSITIONS OF 7-AZONIABICYCLO [2.2.1]HEPTANE DERIVATIVES FOR DRY POWDER INHALERS
EP3723724C0 (en) DRY POWDER INHALER
MA49130A (fr) Nouvelles particules de support pour des formulations de poudre sèche pour l'inhalation
IL278011A (en) Pharmaceutical dry powder composition for inhalation containing thyroid hormone